The stock of PharmaCan Capital Corp (CVE:MJN) is a huge mover today! About 252,024 shares traded hands. PharmaCan Capital Corp (CVE:MJN) has risen 6.00% since October 29, 2016 and is uptrending. It has underperformed by 0.01% the S&P500.
The move comes after 7 months positive chart setup for the $189.95 million company. It was reported on Nov, 28 by Barchart.com. We have $1.73 PT which if reached, will make CVE:MJN worth $11.40M more.
More notable recent PharmaCan Capital Corp (CVE:MJN) news were published by: Marketwatch.com which released: “Jason Adler Announces Increase in Equity Interest in PharmaCan Capital Corp.” on June 08, 2016, also Midasletter.com with their article: “PharmaCan Capital Corp (TSX.V:MJN) CEO Paul Rosen Interview and Podcast” published on February 20, 2015, Marketwired.com published: “PharmaCan Capital Corp. Announces Approval of Increased Production Expansion …” on April 01, 2015. More interesting news about PharmaCan Capital Corp (CVE:MJN) were released by: Marketwired.com and their article: “PharmaCan Capital Corp. Announces Mortgage Financing Relating to In The Zone …” published on February 05, 2015 as well as Marketwired.com‘s news article titled: “PharmaCan Capital Corp. to Open Toronto Stock Exchange” with publication date: January 13, 2015.
PharmaCan Capital Corp., formerly Searchtech Ventures Inc., is a merchant bank, which is focused on investing in Canada’s medical marijuana industry. The company has a market cap of $189.95 million. The Firm is engaged in the business of investing in companies either licensed or seeking a license to produce medical marijuana. It currently has negative earnings. The Firm operates through two divisions: Investing Segment and Operating Segment.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.